Who Are the Leading CDMOs for Complex Synthetic Molecule Manufacturing?
by Developing a complex synthetic molecule is very different from producing a conventional active pharmaceutical ingredient (API). Multi-step synthesis, difficult reaction conditions, impurity control, high-potency compounds, …